Literature DB >> 17922643

Pentaspan membrane glycoprotein, prominin-1, is involved in glucose metabolism and cytoskeleton alteration.

Chang Yang1, Yanli Yang, Nishith Gupta, Xiaojun Liu, Aibin He, Lizhong Liu, Jin Zuo, Yongsheng Chang, Fude Fang.   

Abstract

This study constitutes the first report revealing the participation of prominin-1 in glucose metabolism and cytoskeleton alteration. Upon stimulation with high glucose, the expression of prominin-1 was up-regulated with concomitant down-regulation of its phosphorylation. Prominin-1 mutated at its phosphorylation site inflicted a global change in the expression of several genes associated with glucose metabolism in L6 myotube cells. Further, the over-expression of prominin-1 promoted glucose uptake in these cells. Prominin-1 undergoes sustained repression of its expression during confluence and differentiation of L6 myotube cells. The expression of prominin-1 in the MDCK cell modulated cell morphology and promoted cellular migration. These data imply that prominin-1 is involved in glucose metabolism and may regulate cellular glucose through its effect on cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922643     DOI: 10.1134/s000629790708007x

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  5 in total

1.  The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells.

Authors:  Erika Bourseau-Guilmain; Audrey Griveau; Jean-Pierre Benoit; Emmanuel Garcion
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

2.  Commentary: "prom1 function in development, intestinal inflammation, and intestinal tumorigenesis".

Authors:  Christine A Fargeas; Edgar Büttner; Denis Corbeil
Journal:  Front Oncol       Date:  2015-04-21       Impact factor: 6.244

Review 3.  The role of CD133 in cancer: a concise review.

Authors:  Paige M Glumac; Aaron M LeBeau
Journal:  Clin Transl Med       Date:  2018-07-09

4.  CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro.

Authors:  Marisol Blancas-Mosqueda; Pablo Zapata-Benavides; Diana Zamora-Ávila; Santiago Saavedra-Alonso; Edgar Manilla-Muñoz; Moisés Franco-Molina; Carmen Mondragón DE LA Peña; Cristina Rodríguez-Padilla
Journal:  Exp Ther Med       Date:  2012-08-31       Impact factor: 2.447

Review 5.  Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective.

Authors:  Yongquan Tang; Yan Chen; Zhe Zhang; Bo Tang; Zongguang Zhou; Haining Chen
Journal:  Pharmaceutics       Date:  2021-12-08       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.